TechNavio's analysts forecast the Global Pharmaceuticals market to grow at a CAGR of 7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the rising demand of drugs in the emerging markets. The Global Pharmaceuticals market has also been witnessing a paradigm shift towards biologic drugs. However, the patent expiration of top-selling drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Pharmaceuticals Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pharmaceuticals market landscape by Chemical Properties, by Commercialization, by Legal Consideration, and by Therapeutic Area, and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., and Roche Holding Ltd.
Other vendors mentioned in the report: Abbott Laboratories Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca plc., Baxter International Inc., Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co., Celgene Corp., Cephalon Inc., Eisai Co. Ltd., Eli Lilly and Co., Forest Laboratories Inc., GlaxoSmithKline plc., Hospira Inc., Johnson & Johnson Ltd., Mylan Inc., Novo Nordisk A/S, Otsuka Holdings Co. Ltd., Schering-Plough Corp., Shire plc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical, and UCB S.A.
You can request one free hour of analyst time when you purchase this report. Details provided within the report.